http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114732788-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38de6562fb0feaae2c4563e3a130b1b4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
filingDate 2022-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66995493e4b0705963c67a3be9666486
publicationDate 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114732788-A
titleOfInvention A kind of clopidogrel hydrogen sulfate solid preparation and preparation process thereof
abstract The invention provides a clopidogrel hydrogen sulfate solid preparation and a preparation process thereof, belonging to the field of pharmaceutical preparations. The solid preparation of clopidogrel hydrogen sulfate, by weight percentage, comprises 0.1-30% of clopidogrel, 20-50% of filler, 1-5% of solubilizer, 3-10% of binder, and lubricant and glidant 1‑10%, sweeteners 10‑35% and aromatic flavorings 0.5‑10%. In the implementation process, the present invention adopts polyoxyethylene (8) stearate as a solubilizer, which can significantly improve the dissolution of the drug in vitro, and adopts hydroxypropyl cellulose as a binder to enhance the stability of the solid preparation of clopidogrel hydrogen sulfate. In addition, the present invention avoids the direct contact of clopidogrel with light and damp heat by embedding clopidogrel, and adopts a fluidized bed one-step granulation process, which fundamentally avoids the production process of traditional clopidogrel hydrogen sulfate preparations. Degradation problems that are prone to occur, improve drug stability.
priorityDate 2022-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008065674-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009028900-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008001201-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID454730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548823
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID445380
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453635562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID685269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID89151
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448700180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24883467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID89151
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3674
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403789
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16399

Total number of triples: 59.